SENSEX NIFTY

Glenmark Pharmaceuticals

Jul 25, 2014 at 22:11 | Source: Moneycontrol.com
Glenmark Pharmaceuticals has informed that the Annual General Meeting (AGM) of the Company was held on July 25, 2014.
Jul 25, 2014 at 14:49 | Source: Moneycontrol.com
Macquarie maintains outperform with a target of Rs 835 per share. The brokerage expects emerging markets strong growth momentum to continue and is hoping the US markets to pick up in second half, which was subdued due to lack of approvals in Q1FY15.
Jul 25, 2014 at 11:23 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Dr Reddy's Laboratories, Glenmark Pharma, Shasun Pharmaceuticals and Ranbaxy Laboratories will be getting astrological support.
Jul 25, 2014 at 10:04 | Source: Moneycontrol.com
The company told analysts that it has received USD 5 million from Sanofi as licensing fee. It said its clinical trials for GBR 900 were progressing well.
Jul 24, 2014 at 21:42 | Source: Moneycontrol.com
Glenmark Pharmaceuticals at its Meeting held on July 24, 2014 allotted 24,100 equity shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.
Jul 24, 2014 at 16:32 | Source: PTI
The company's consolidated revenue was up 20 percent at Rs 1,487 crore versus Rs 1,238.2 crore, Y-o-Y.
Jul 24, 2014 at 11:10 | Source: Moneycontrol.com
Sales are expected to decrease by 0.8 percent quarter-on-quarter (growth of 34.8 percent Y-o-Y) to Rs 1668.6 crore, according to Prabhudas Lilladher.
Jul 24, 2014 at 10:42 | Source: CNBC-TV18
Revenue may grow 24.4 percent to Rs 1,541 crore in the quarter ended June 2014 compared to Rs 1,238 crore in same quarter last fiscal, which is lower compared to 27.5 percent growth in Q4FY14 revenue.
Jul 23, 2014 at 11:37 | Source: CNBC-TV18
Jeff Chowdhry, Head of Emerging Market Equities at F&C Investments is of the view that one may prefer HDFC Bank, ICICI Bank, TCS, Lupin and Glenmark Pharma.
Jul 17, 2014 at 15:54 | Source: Moneycontrol.com
Glenmark Pharmaceuticals plans to set up this manufacturing facility at Monroe Corporate Center, North Carolina, USA. The facility will be spread over 1 lakh square feet and the company will first begin work on an oral solid unit and thereafter it will set up manufacturing units for injectables and topicals.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

3556 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th

BSE/NSE Announcer

Platinum Member

3556 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th

BSE/NSE Announcer

Platinum Member

3556 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th

BSE/NSE Announcer

Platinum Member

3556 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd

BSE/NSE Announcer

Platinum Member

3556 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th

adviserbola

Platinum Member

213 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th

Amrita Gaba

New Member

329 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th

BSE/NSE Announcer

Platinum Member

3556 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th

News across the web »
May 09, 2014 at 10:56 | Source: Economic Times
May 04, 2014 at 18:02 | Source: Business Today
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.